Shengping Li

797 total citations
28 papers, 565 citations indexed

About

Shengping Li is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shengping Li has authored 28 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Shengping Li's work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Gallbladder and Bile Duct Disorders (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Shengping Li is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), Gallbladder and Bile Duct Disorders (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Shengping Li collaborates with scholars based in China, United States and Taiwan. Shengping Li's co-authors include Yize Mao, Guo‐He Lin, Xiang‐Ming Lao, Xiaojun Lin, Jianlin Chen, Zeyu Shuang, Chaobin He, Xin Huang, Jun Wang and Yongcheng Liu and has published in prestigious journals such as Journal of Biological Chemistry, Frontiers in Immunology and Cancer Letters.

In The Last Decade

Shengping Li

25 papers receiving 558 citations

Peers

Shengping Li
Teruhisa Sonoyama Japan
Hans‐Peter Allgaier Germany
Niek A. Peters Netherlands
Takashi Seino Japan
Giorgio Frega Italy
Vittorio Branchi Germany
Feiling Feng China
Yu Sawada Japan
Yusuke Ohara Japan
Kambiz Kosari United States
Teruhisa Sonoyama Japan
Shengping Li
Citations per year, relative to Shengping Li Shengping Li (= 1×) peers Teruhisa Sonoyama

Countries citing papers authored by Shengping Li

Since Specialization
Citations

This map shows the geographic impact of Shengping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengping Li more than expected).

Fields of papers citing papers by Shengping Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengping Li. The network helps show where Shengping Li may publish in the future.

Co-authorship network of co-authors of Shengping Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengping Li. A scholar is included among the top collaborators of Shengping Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengping Li. Shengping Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Lingmin, et al.. (2024). Triglyceride-glucose index and glycemic dynamics in pancreatic ductal adenocarcinoma: implications for disease progression and prognosis. Journal of Translational Medicine. 22(1). 708–708. 3 indexed citations
2.
3.
Jiang, Lingmin, Xin Huang, Xin Hua, et al.. (2024). Treatment of locally advanced pancreatic cancer with irreversible electroporation and intraoperative radiotherapy. HepatoBiliary Surgery and Nutrition. 13(6). 1087–1090.
4.
Jiang, Qi, Jinsheng Huang, Bei Zhang, et al.. (2022). Efficacy and Safety of Anti-PD1/PDL1 in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 801909–801909. 8 indexed citations
5.
Chen, Chen, Yongjie Zhang, Ning Yang, et al.. (2021). Optimal Lymph Node Staging System in Evaluating Prognosis of Gallbladder Carcinoma: A Multi-institutional Study. Annals of Surgical Oncology. 28(13). 8142–8151. 10 indexed citations
6.
Chen, Chen, Rui Zhang, Yongjie Zhang, et al.. (2021). ASO Visual Abstract: Optimal Lymph Node Staging System in Evaluating Prognosis of Gallbladder Carcinoma: A Multi-Institutional Study. Annals of Surgical Oncology. 28(S3). 719–719.
7.
Wu, Yuhan, Zhiqiang Cai, Yongjie Zhang, et al.. (2020). Survival prediction for gallbladder carcinoma after curative resection: Comparison of nomogram and Bayesian network models. European Journal of Surgical Oncology. 46(11). 2106–2113. 12 indexed citations
8.
Lu, Lianghe, et al.. (2020). A Novel Prognostic Nomogram for Patients With Recurrence of Intrahepatic Cholangiocarcinoma After Initial Surgery. Frontiers in Oncology. 10. 434–434. 11 indexed citations
9.
Li, QiJiong, et al.. (2019). Clinical practice of basin-shaped hepaticojejunostomy following hilar resection of stage III/IV hilar cholangiocarcinoma. BMC Gastroenterology. 19(1). 99–99. 4 indexed citations
10.
11.
Sui, Meirong, Shengping Li, & Xiuquan Gu. (2019). Improved performance of perovskite solar cells through using (FA)x(MA)1-xPbI3 optical absorber layer. Optoelectronics Letters. 15(2). 117–121. 16 indexed citations
12.
He, Chaobin, Yize Mao, Jun Wang, et al.. (2018). Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema. Journal of Cancer. 9(9). 1667–1679. 16 indexed citations
13.
14.
He, Chaobin, Yize Mao, Jun Wang, et al.. (2018). The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study. Journal of Gastrointestinal Surgery. 22(7). 1239–1250. 28 indexed citations
15.
Huang, Kai‐Wen, P. C. Yang, Uei Pua, et al.. (2018). The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma. Journal of Surgical Oncology. 118(1). 31–36. 32 indexed citations
16.
Wang, Juncheng, Yize Mao, Yongcheng Liu, et al.. (2017). Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment. Journal of Gastrointestinal Surgery. 21(7). 1128–1135. 19 indexed citations
17.
18.
19.
20.
Zhao, Wei, Bing Qi, Qian Yang, et al.. (2014). DNA Methylation-mediated Repression of miR-941 Enhances Lysine (K)-specific Demethylase 6B Expression in Hepatoma Cells. Journal of Biological Chemistry. 289(35). 24724–24735. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teruhisa Sonoyama Breakdown of academic impact, for papers by Hans‐Peter Allgaier Breakdown of academic impact, for papers by Niek A. Peters Breakdown of academic impact, for papers by Takashi Seino Breakdown of academic impact, for papers by Giorgio Frega Breakdown of academic impact, for papers by Vittorio Branchi Breakdown of academic impact, for papers by Feiling Feng Breakdown of academic impact, for papers by Yu Sawada Breakdown of academic impact, for papers by Yusuke Ohara Breakdown of academic impact, for papers by Kambiz Kosari
Rankless by CCL
2026